Literature DB >> 11129635

The vaccinia virus E3L protein interacts with SUMO-1 and ribosomal protein L23a in a yeast two hybrid assay.

S Rogan1, S Heaphy.   

Abstract

We report the results of a two-hybrid study which identified clones from a HeLa cDNA library that interact with the vaccinia virus protein E3L. These clones encode the nuclear protein SUMO-1 (also known as PIC-1, sentrin or GMP-1); the cytoplasmic ribosomal protein L23a; and a small peptide sequence of unknown significance.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11129635     DOI: 10.1023/a:1008139514123

Source DB:  PubMed          Journal:  Virus Genes        ISSN: 0920-8569            Impact factor:   2.198


  12 in total

1.  Distinct patterns of IFN sensitivity observed in cells infected with vaccinia K3L- and E3L- mutant viruses.

Authors:  E Beattie; E Paoletti; J Tartaglia
Journal:  Virology       Date:  1995-07-10       Impact factor: 3.616

2.  The vaccinia virus E3L gene product interacts with both the regulatory and the substrate binding regions of PKR: implications for PKR autoregulation.

Authors:  T V Sharp; F Moonan; A Romashko; B Joshi; G N Barber; R Jagus
Journal:  Virology       Date:  1998-10-25       Impact factor: 3.616

Review 3.  When two strands are better than one: the mediators and modulators of the cellular responses to double-stranded RNA.

Authors:  B L Jacobs; J O Langland
Journal:  Virology       Date:  1996-05-15       Impact factor: 3.616

4.  Ribosome targeting of PKR is mediated by two double-stranded RNA-binding domains and facilitates in vivo phosphorylation of eukaryotic initiation factor-2.

Authors:  S Zhu; P R Romano; R C Wek
Journal:  J Biol Chem       Date:  1997-05-30       Impact factor: 5.157

5.  A small ubiquitin-related polypeptide involved in targeting RanGAP1 to nuclear pore complex protein RanBP2.

Authors:  R Mahajan; C Delphin; T Guan; L Gerace; F Melchior
Journal:  Cell       Date:  1997-01-10       Impact factor: 41.582

6.  Nuclear localization of a double-stranded RNA-binding protein encoded by the vaccinia virus E3L gene.

Authors:  H Yuwen; J H Cox; J W Yewdell; J R Bennink; B Moss
Journal:  Virology       Date:  1993-08       Impact factor: 3.616

Review 7.  Nuclear dots: actors on many stages.

Authors:  T Sternsdorf; T Grötzinger; K Jensen; H Will
Journal:  Immunobiology       Date:  1997-12       Impact factor: 3.144

8.  Complementation of vaccinia virus deleted of the E3L gene by mutants of E3L.

Authors:  T Shors; K V Kibler; K B Perkins; R Seidler-Wulff; M P Banaszak; B L Jacobs
Journal:  Virology       Date:  1997-12-22       Impact factor: 3.616

9.  The E3L gene of vaccinia virus encodes an inhibitor of the interferon-induced, double-stranded RNA-dependent protein kinase.

Authors:  H W Chang; J C Watson; B L Jacobs
Journal:  Proc Natl Acad Sci U S A       Date:  1992-06-01       Impact factor: 11.205

10.  Human p68 kinase exhibits growth suppression in yeast and homology to the translational regulator GCN2.

Authors:  K L Chong; L Feng; K Schappert; E Meurs; T F Donahue; J D Friesen; A G Hovanessian; B R Williams
Journal:  EMBO J       Date:  1992-04       Impact factor: 11.598

View more
  11 in total

Review 1.  Human pathogens and the host cell SUMOylation system.

Authors:  Peter Wimmer; Sabrina Schreiner; Thomas Dobner
Journal:  J Virol       Date:  2011-11-09       Impact factor: 5.103

2.  SUMOylation of the human cytomegalovirus 72-kilodalton IE1 protein facilitates expression of the 86-kilodalton IE2 protein and promotes viral replication.

Authors:  Michael Nevels; Wolfram Brune; Thomas Shenk
Journal:  J Virol       Date:  2004-07       Impact factor: 5.103

3.  Regulation of vaccinia virus E3 protein by small ubiquitin-like modifier proteins.

Authors:  José González-Santamaría; Michela Campagna; María Angel García; Laura Marcos-Villar; Dolores González; Pedro Gallego; Fernando Lopitz-Otsoa; Susana Guerra; Manuel S Rodríguez; Mariano Esteban; Carmen Rivas
Journal:  J Virol       Date:  2011-09-28       Impact factor: 5.103

Review 4.  Poxvirus proteomics and virus-host protein interactions.

Authors:  Kim Van Vliet; Mohamed R Mohamed; Leiliang Zhang; Nancy Yaneth Villa; Steven J Werden; Jia Liu; Grant McFadden
Journal:  Microbiol Mol Biol Rev       Date:  2009-12       Impact factor: 11.056

5.  Quantitative SUMO-1 modification of a vaccinia virus protein is required for its specific localization and prevents its self-association.

Authors:  Silvia Palacios; Laurent H Perez; Sonja Welsch; Sibylle Schleich; Katarzyna Chmielarska; Frauke Melchior; Jacomine Krijnse Locker
Journal:  Mol Biol Cell       Date:  2005-03-30       Impact factor: 4.138

Review 6.  Molecular mechanisms of viral inhibitors of RIG-I-like receptors.

Authors:  Daisy W Leung; Christopher F Basler; Gaya K Amarasinghe
Journal:  Trends Microbiol       Date:  2012-02-08       Impact factor: 17.079

7.  Small ubiquitin-related modifier-1 modification mediates resolution of CREB-dependent responses to hypoxia.

Authors:  Katrina M Comerford; Martin O Leonard; Jorn Karhausen; Robyn Carey; Sean P Colgan; Cormac T Taylor
Journal:  Proc Natl Acad Sci U S A       Date:  2003-01-27       Impact factor: 11.205

8.  cDNA cloning, overexpression, purification and pharmacologic evaluation for anticancer activity of ribosomal protein L23A gene (RPL23A) from the Giant Panda.

Authors:  Bing Sun; Yi-Ling Hou; Wan-Ru Hou; Si-Nan Zhang; Xiang Ding; Xiu-Lan Su
Journal:  Int J Mol Sci       Date:  2012-02-16       Impact factor: 6.208

9.  Analysis of vaccinia virus-host protein-protein interactions: validations of yeast two-hybrid screenings.

Authors:  Leiliang Zhang; Nancy Y Villa; Masmudur M Rahman; Sherin Smallwood; Donna Shattuck; Chris Neff; Max Dufford; Jerry S Lanchbury; Joshua Labaer; Grant McFadden
Journal:  J Proteome Res       Date:  2009-09       Impact factor: 4.466

10.  Proteomic analysis of differentially expressed proteins in Fenneropenaeus chinensis hemocytes upon white spot syndrome virus infection.

Authors:  Wei Li; Xiaoqian Tang; Jing Xing; Xiuzhen Sheng; Wenbin Zhan
Journal:  PLoS One       Date:  2014-02-27       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.